600518 康美药业
已收盘 09-30 15:00:00
资讯
新帖
简况
股市必读：康美药业（600518）9月24日董秘有最新回复
证券之星 · 09-28
股市必读：康美药业（600518）9月24日董秘有最新回复
投保渗透率6年增3倍 董责险渐成企业“标配”
中国经营网 · 09-26
投保渗透率6年增3倍 董责险渐成企业“标配”
康美药业：集体诉讼追偿案二审尚未开庭审理
证券之星 · 09-24
康美药业：集体诉讼追偿案二审尚未开庭审理
每周股票复盘：康美药业（600518）选举孟君为董事长
证券之星 · 09-13
每周股票复盘：康美药业（600518）选举孟君为董事长
股市必读：康美药业新发布《康美药业第十届董事会2026年度第六次临时会议决议公告》
证券之星 · 09-09
股市必读：康美药业新发布《康美药业第十届董事会2026年度第六次临时会议决议公告》
康美药业最新公告：选举孟君为董事长
证券之星 · 09-07
康美药业最新公告：选举孟君为董事长
股市必读：康美药业新发布《康美药业关于召开2026年半年度业绩说明会的公告》
证券之星 · 09-07
股市必读：康美药业新发布《康美药业关于召开2026年半年度业绩说明会的公告》
康美药业（600518）披露2026年半年度业绩说明会公告，9月3日股价下跌1.44%
证券之星 · 09-03
康美药业（600518）披露2026年半年度业绩说明会公告，9月3日股价下跌1.44%
康美药业新注册《康美·中药集采订单智能采集与分发系统V1.0》等2个项目的软件著作权
证券之星 · 09-01
康美药业新注册《康美·中药集采订单智能采集与分发系统V1.0》等2个项目的软件著作权
康美药业（600518）2026年中报简析：净利润同比增长113.21%，盈利能力上升
证券之星 · 08-27
康美药业（600518）2026年中报简析：净利润同比增长113.21%，盈利能力上升
康美药业（600518）披露2026年半年度报告，8月25日股价上涨2.24%
证券之星 · 08-25
康美药业（600518）披露2026年半年度报告，8月25日股价上涨2.24%
康美药业2026年半年报：资产处置增厚利润，扣非净利润仍亏损
蓝鲸财经 · 08-25
康美药业2026年半年报：资产处置增厚利润，扣非净利润仍亏损
康美药业（600518）披露关于选举孟君先生为董事的议案，8月21日股价下跌2.16%
证券之星 · 08-21
康美药业（600518）披露关于选举孟君先生为董事的议案，8月21日股价下跌2.16%
康美药业：已聘请国内头部券商协助开展市值管理相关工作
证券之星 · 08-06
康美药业：已聘请国内头部券商协助开展市值管理相关工作
康美药业：抵债股票由管理人进行公开处置
证券之星 · 08-06
康美药业：抵债股票由管理人进行公开处置
康美药业：董事及高级管理人员2026年度薪酬由基本薪酬和绩效奖金组成
证券之星 · 08-06
康美药业：董事及高级管理人员2026年度薪酬由基本薪酬和绩效奖金组成
康美药业：公司目前生产经营正常
证券之星 · 08-06
康美药业：公司目前生产经营正常
康美药业：已建立股价动态监测机制
证券之星 · 08-06
康美药业：已建立股价动态监测机制
康美药业：率先进入更高端的中药饮片市场
证券之星 · 08-06
康美药业：率先进入更高端的中药饮片市场
康美药业：中药配方颗粒、趁鲜加工已纳入统一追溯体系
证券之星 · 08-06
康美药业：中药配方颗粒、趁鲜加工已纳入统一追溯体系
加载更多
公司概况
公司名称：
康美药业股份有限公司
所属行业：
医药制造业
上市日期：
2001-03-19
主营业务：
康美药业股份有限公司的主营业务是以中药饮片生产、销售为核心，实施中医药全产业链一体化运营。公司的主要产品是中药饮片、中成药、化学药、保健食品及食品。公司是国家技术创新示范企业、国家知识产权示范企业。
发行价格：
12.57
{"stockData":{"symbol":"600518","market":"SH","secType":"STK","nameCN":"康美药业","latestPrice":1.34,"timestamp":1790751600000,"preClose":1.33,"halted":0,"volume":84827508,"delay":0,"changeRate":0.0075,"floatShares":13822000000,"shares":13829000000,"eps":0.0022,"marketStatus":"已收盘","change":0.01,"latestTime":"09-30 15:00:00","open":1.33,"high":1.35,"low":1.32,"amount":114000000,"amplitude":0.0226,"askPrice":1.35,"askSize":97501,"bidPrice":1.34,"bidSize":94332,"shortable":0,"etf":0,"ttmEps":0.0022,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791423000000},"marketStatusCode":5,"adr":0,"adjPreClose":1.33,"symbolType":"stock","openAndCloseTimeList":[[1790731800000,1790739000000],[1790744400000,1790751600000]],"highLimit":1.46,"lowLimit":1.2,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":13828896690,"isCdr":false,"pbRate":2.53,"roa":"--","peRate":609.090909,"roe":"0.49%","epsLYR":0.0007,"committee":0.014271,"marketValue":18531000000,"turnoverRate":0.0061,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-10-08。","floatMarketCap":18522000000},"requestUrl":"/m/hq/s/600518/","defaultTab":"news","newsList":[{"id":"2670401561","title":"股市必读：康美药业（600518）9月24日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2670401561","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670401561?lang=zh_cn&edition=full","pubTime":"2026-09-28 03:04","pubTimestamp":1790535858,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘，康美药业报收于1.33元，下跌1.48%，换手率0.8%，成交量110.3万手，成交额1.48亿元。董秘最新回复投资者： 董秘您好，445 号追偿一审判决后，马兴田等人处于公告送达阶段，杭州中院 241 号已经冻结其相关股权。投资者： 董秘您好，亳州三家子公司 28.2 亿元担保仍有效，债权已转让信达资产安徽分公司，相关主体已被限消。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800001514.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0196","BK0188","BK0096","BK0028","BK0183","BK0097","BK0012","BK0187","BK0239","BK0077","600518","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670213364","title":"投保渗透率6年增3倍 董责险渐成企业“标配”","url":"https://stock-news.laohu8.com/highlight/detail?id=2670213364","media":"中国经营网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670213364?lang=zh_cn&edition=full","pubTime":"2026-09-26 02:16","pubTimestamp":1790360178,"startTime":"0","endTime":"0","summary":"A股上市公司正加速将董责险从“可选配置”推向“刚需标配”。《中国经营报》记者通过Wind平台梳理发现，仅9月份以来，麦克奥迪（300341.SZ）、*ST禾信（688622.SH）、全新好（000007.SZ）、郴电国际（600969.SH）等十余家上市公司在公告中提及购买董责险事宜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://insurance.eastmoney.com/a/202609263884349658.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://insurance.eastmoney.com/a/202609263884349658.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02843","BK0175","BK0225","399300","300341","82846","BK0224","BK0028","BK0273","BK0190","03130","688622","BK0077","BK0271","03188","600969","BK0146","BK0188","02827","BK0183","07233","BK0139","600518","BK0196","BK1147","83130","159982","82822","02846","82823","BK0187","83188","82843","BK0096","BK1610","BK0012","BK0239","02823","02822","BK0097","000007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669465776","title":"康美药业：集体诉讼追偿案二审尚未开庭审理","url":"https://stock-news.laohu8.com/highlight/detail?id=2669465776","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669465776?lang=zh_cn&edition=full","pubTime":"2026-09-24 17:12","pubTimestamp":1790241131,"startTime":"0","endTime":"0","summary":"证券之星消息，康美药业09月24日在投资者关系平台上答复投资者关心的问题。目前集体诉讼追偿案二审尚未开庭审理，最终判决结果存在不确定性，公司尚无法预计本次诉讼对公司损益产生的影响。前期公司已对相关财产采取申请保全措施，公司将依据法律相关规定，积极行使诉讼权利，维护公司及股东的合法权益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400029431.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0175","BK0146","BK0239","BK0183","BK0028","600518","BK0196","BK0188","BK0012","BK0097","BK0096","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667550767","title":"每周股票复盘：康美药业（600518）选举孟君为董事长","url":"https://stock-news.laohu8.com/highlight/detail?id=2667550767","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667550767?lang=zh_cn&edition=full","pubTime":"2026-09-13 02:05","pubTimestamp":1789236314,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，康美药业报收于1.38元，较上周的1.38元上涨0.0%。公司公告汇总：临时股东会审议通过选举孟君为董事，同意票占比96.3331%。董事会同意补选孟君先生为第十届董事会战略委员会召集人、审计委员会委员。表决结果显示A股股东同意票占96.3331%，议案获有效表决权过半数通过。康美药业股份有限公司于2026年9月7日召开第十届董事会2026年度第六次临时会议，审议通过选举孟君先生为公司董事长，任期至第十届董事会届满。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300000493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600518","BK0146","BK0183","BK0096","BK0077","BK0188","BK0012","BK0097","BK0196","BK0239","BK0175","BK0028","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666748873","title":"股市必读：康美药业新发布《康美药业第十届董事会2026年度第六次临时会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2666748873","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666748873?lang=zh_cn&edition=full","pubTime":"2026-09-09 00:24","pubTimestamp":1788884656,"startTime":"0","endTime":"0","summary":"公司公告汇总康美药业第十届董事会2026年度第六次临时会议决议公告康美药业股份有限公司于2026年9月7日召开第十届董事会2026年度第六次临时会议，审议通过豁免本次会议通知期限的议案；选举孟君先生为公司董事长，任期至第十届董事会届满，孟君先生同时担任公司法定代表人；同意补选孟君先生为第十届董事会战略委员会召集人、审计委员会委员。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900001179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0097","BK0146","BK0096","BK0175","BK0187","BK0012","BK0239","BK0028","BK0188","BK0077","BK0183","600518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665314170","title":"康美药业最新公告：选举孟君为董事长","url":"https://stock-news.laohu8.com/highlight/detail?id=2665314170","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665314170?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:56","pubTimestamp":1788774964,"startTime":"0","endTime":"0","summary":"康美药业(600518.SH)公告称，公司董事会选举孟君担任第十届董事会董事长，任期至本届董事会届满。根据公司章程，孟君自当选之日起任法定代表人。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700023655.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0028","600518","BK0187","BK0183","BK0188","BK0239","BK0097","BK0146","BK0012","BK0077","BK0096","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665627303","title":"股市必读：康美药业新发布《康美药业关于召开2026年半年度业绩说明会的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2665627303","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665627303?lang=zh_cn&edition=full","pubTime":"2026-09-07 01:12","pubTimestamp":1788714731,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，康美药业报收于1.38元，上涨0.73%，换手率1.02%，成交量141.06万手，成交额1.95亿元。公司公告汇总：康美药业将于9月11日召开2026年半年度业绩说明会，投资者可于9月4日至10日16:00前预约提问。交易信息汇总资金流向9月4日主力资金净流出408.5万元，占总成交额2.09%；游资资金净流入290.15万元，占总成交额1.49%；散户资金净流入118.34万元，占总成交额0.61%。会后可通过上证路演中心查看会议情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700000589.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0077","BK0096","BK0028","600518","BK0175","BK0196","BK0187","BK0183","BK0188","BK0146","BK0012","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664870501","title":"康美药业（600518）披露2026年半年度业绩说明会公告，9月3日股价下跌1.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664870501","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664870501?lang=zh_cn&edition=full","pubTime":"2026-09-03 22:06","pubTimestamp":1788444387,"startTime":"0","endTime":"0","summary":"截至2026年9月3日收盘，康美药业报收于1.37元，较前一交易日下跌1.44%，最新总市值为189.46亿元。近日，康美药业发布《关于召开2026年半年度业绩说明会的公告》。公告显示，公司将于2026年9月11日15:00-16:00通过上海证券交易所上证路演中心以网络互动方式召开2026年半年度业绩说明会，介绍公司经营成果和财务状况。投资者可于2026年9月4日至9月10日16:00前通过上证路演中心网站或公司邮箱kangmei@kangmei.com.cn提问。会后可通过上证路演中心查看会议情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300042167.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600518","BK0239","BK0077","BK0097","BK0012","BK0188","BK0175","BK0028","BK0196","BK0146","BK0187","BK0183","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664000620","title":"康美药业新注册《康美·中药集采订单智能采集与分发系统V1.0》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000620","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664000620?lang=zh_cn&edition=full","pubTime":"2026-09-01 02:37","pubTimestamp":1788201432,"startTime":"0","endTime":"0","summary":"证券之星消息，近日康美药业（600518）新注册了2个项目的软件著作权，包括《康美·中药集采订单智能采集与分发系统V1.0》、《康美·中药集采订单全流程协同智能管控系统V1.0》等。今年以来康美药业新注册软件著作权4个。结合公司2026年中报财务数据，今年上半年公司在研发方面投入了1366.43万元，同比减23.72%。通过天眼查大数据分析，康美药业股份有限公司共对外投资了61家企业，参与招投标项目959次；财产线索方面有商标信息2982条，专利信息579条，著作权信息159条；此外企业还拥有行政许可124个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100002450.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0183","159180","BK0097","600518","BK0096","BK0146","BK0188","BK0196","BK0077","BK0175","BK0012","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662936740","title":"康美药业（600518）2026年中报简析：净利润同比增长113.21%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2662936740","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662936740?lang=zh_cn&edition=full","pubTime":"2026-08-27 06:05","pubTimestamp":1787781917,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期康美药业发布2026年中报。截至本报告期末，公司营业总收入22.9亿元，同比下降11.13%，归母净利润3603.48万元，同比上升113.21%。按单季度数据看，第二季度营业总收入12.11亿元，同比下降5.27%，第二季度归母净利润5259.87万元，同比上升526.5%。本报告期康美药业盈利能力上升，毛利率同比增幅13.08%，净利率同比增幅129.58%。去年的净利率为0.24%，算上全部成本后，公司产品或服务的附加值不高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700010904.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662075843","title":"康美药业（600518）披露2026年半年度报告，8月25日股价上涨2.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662075843","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662075843?lang=zh_cn&edition=full","pubTime":"2026-08-25 22:14","pubTimestamp":1787667265,"startTime":"0","endTime":"0","summary":"截至2026年8月25日收盘，康美药业报收于1.37元，较前一交易日上涨2.24%，最新总市值为189.46亿元。该股当日开盘1.34元，最高1.38元，最低1.33元，成交额达1.75亿元，换手率为0.93%。近日，康美药业发布2026年半年度报告。公告显示，截至报告期末，公司总资产为13,067,976,859.46元，较上年度末减少1.15%；归属于上市公司股东的净资产为7,325,686,836.82元，较上年度末增长0.49%。经营活动产生的现金流量净额为36,052,843.51元，上年同期为-82,116,847.68元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500050431.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0187","600518","BK0077","BK0097","BK0146","BK0096","BK0183","BK0175","BK0196","BK0028","BK0188","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662051738","title":"康美药业2026年半年报：资产处置增厚利润，扣非净利润仍亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=2662051738","media":"蓝鲸财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662051738?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:52","pubTimestamp":1787651555,"startTime":"0","endTime":"0","summary":"财报数据显示，报告期公司实现营业收入22.90亿元，同比下降11.13%；归母净利润3603.48万元，同比增长113.21%；扣除非经常性损益后的净利润为-5958.74万元，同比亏损扩大。报告期公司投资收益达8161.24万元，主要系处置全资子公司上海德大堂国药有限公司股权产生收益所致；同时，资产处置收益及债务重组收益也对利润形成正向贡献。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1787649932080863172","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["600518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661073295","title":"康美药业（600518）披露关于选举孟君先生为董事的议案，8月21日股价下跌2.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661073295","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661073295?lang=zh_cn&edition=full","pubTime":"2026-08-21 22:08","pubTimestamp":1787321280,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，康美药业报收于1.36元，较前一交易日下跌2.16%，最新总市值为188.07亿元。近日，康美药业发布《关于召开2026年第二次临时股东会的通知》，公告显示公司将于2026年9月7日召开2026年第二次临时股东会，会议审议《关于选举孟君先生为董事的议案》，并对中小投资者单独计票。股权登记日为2026年9月1日，现场会议地点为广东省普宁市科技工业园康美药业中药生产基地二期综合楼会议室。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100045118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0196","BK0146","BK0097","BK0077","BK0183","BK0096","BK0012","600518","BK0028","BK0239","BK0175","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657868148","title":"康美药业：已聘请国内头部券商协助开展市值管理相关工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2657868148","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657868148?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:36","pubTimestamp":1786009018,"startTime":"0","endTime":"0","summary":"证券之星消息，康美药业08月06日在投资者关系平台上答复投资者关心的问题。必须立即采取市值管理措施！公司目前生产经营正常，股票价格受宏观经济形势、市场行情等多种因素影响，敬请广大投资者注意二级市场交易风险。现阶段公司已建立股价动态监测机制，已聘请国内头部券商协助开展市值管理相关工作，维护公司长期稳定发展及全体股东利益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600029289.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0183","BK0097","BK0188","BK0196","BK0077","BK0239","BK0175","BK0187","BK0028","600518","BK0146","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657681483","title":"康美药业：抵债股票由管理人进行公开处置","url":"https://stock-news.laohu8.com/highlight/detail?id=2657681483","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657681483?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:36","pubTimestamp":1786008998,"startTime":"0","endTime":"0","summary":"根据《重整计划》，提存的偿债资金、股票或信托受益权自重整计划执行完毕之日起满三年，因债权人自身原因仍不领取的，视为放弃受领清偿款项的权利；已提存的偿债资金将用于补充康美药业流动资金；抵债股票由管理人进行公开处置，处置变现价款在支付必要的处置税费后用于补充上市公司经营性流动资金；信托受益权归属于公司，收益扣除信托费用后用于补充上市公司流动资金。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600029260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0175","BK0188","BK0183","BK0196","BK0239","BK0146","BK0096","BK0012","BK0077","BK0187","BK0028","600518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657681430","title":"康美药业：董事及高级管理人员2026年度薪酬由基本薪酬和绩效奖金组成","url":"https://stock-news.laohu8.com/highlight/detail?id=2657681430","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657681430?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:36","pubTimestamp":1786008998,"startTime":"0","endTime":"0","summary":"公司已建立《董事及高级管理人员薪酬管理制度》，并制定董事、高级管理人员2026年度薪酬方案。在公司担任除董事之外的其他职务并且参与日常公司经营管理的非独立董事及公司高级管理人员2026年度薪酬由基本薪酬和绩效奖金组成，其中绩效奖金占比原则上不低于基本薪酬与绩效奖金总额的50%，与公司年度和任期的经营业绩、绩效考评结果挂钩。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600029256.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0097","BK0028","BK0183","BK0188","BK0012","BK0239","BK0175","BK0096","BK0196","BK0146","BK0187","600518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657681176","title":"康美药业：公司目前生产经营正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2657681176","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657681176?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:36","pubTimestamp":1786008997,"startTime":"0","endTime":"0","summary":"证券之星消息，康美药业08月06日在投资者关系平台上答复投资者关心的问题。公司目前生产经营正常，股票价格受宏观经济形势、市场行情等多种因素影响，敬请广大投资者注意二级市场交易风险。公司持续关注股价走势，不断完善公司治理、提升经营质量，高度重视投资者关系管理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600029251.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0175","BK0146","BK0239","BK0183","BK0028","600518","BK0196","BK0188","BK0012","BK0097","BK0096","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657121681","title":"康美药业：已建立股价动态监测机制","url":"https://stock-news.laohu8.com/highlight/detail?id=2657121681","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657121681?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:36","pubTimestamp":1786008985,"startTime":"0","endTime":"0","summary":"证券之星消息，康美药业08月06日在投资者关系平台上答复投资者关心的问题。公司既无回购也无增持，投资者保护措施形同虚设。请制定明确的股东回报规划及实施时间表。现阶段公司已建立股价动态监测机制，已聘请国内头部券商协助开展市值管理相关工作，维护公司长期稳定发展及全体股东利益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600029237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0196","600518","BK0175","BK0239","BK0028","BK0187","BK0146","BK0183","BK0097","BK0096","BK0012","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657144681","title":"康美药业：率先进入更高端的中药饮片市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2657144681","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657144681?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:36","pubTimestamp":1786008974,"startTime":"0","endTime":"0","summary":"证券之星消息，康美药业08月06日在投资者关系平台上答复投资者关心的问题。关于中药饮片集采，公司主动将主战场锚定选货赛道，率先进入更高端的中药饮片市场。近期，新一轮全国中药饮片联盟（第二轮）集中采购结果正式落地，公司中选41个选货、25个统货，选货品种占比远超同行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600029230.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0187","600518","BK0183","BK0077","BK0012","BK0239","BK0096","BK0097","BK0196","BK0028","BK0146","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657814356","title":"康美药业：中药配方颗粒、趁鲜加工已纳入统一追溯体系","url":"https://stock-news.laohu8.com/highlight/detail?id=2657814356","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657814356?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:36","pubTimestamp":1786008972,"startTime":"0","endTime":"0","summary":"证券之星消息，康美药业08月06日在投资者关系平台上答复投资者关心的问题。智慧药房药事服务追溯系统是否与生产端追溯码全链路打通，患者扫码能否查看全流程信息？公司的中药配方颗粒、趁鲜加工溯源系统建设是参考国标进行规划和建设，目前已纳入统一追溯体系。公司将积极参与饮片溯源相关标准的起草工作，密切跟踪国家政策，不断完善公司饮片和药事服务的追溯体系建设。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600029225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0187","600518","BK0196","BK0239","BK0097","BK0146","BK0188","BK0183","BK0096","BK0175","BK0028","BK0077"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1790960815441,"stockEarnings":[{"period":"1week","weight":-0.0074},{"period":"1month","weight":-0.029},{"period":"3month","weight":0.0388},{"period":"6month","weight":-0.2343},{"period":"1year","weight":-0.3366},{"period":"ytd","weight":-0.2984}],"compareEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":-0.0362},{"period":"3month","weight":-0.0463},{"period":"6month","weight":-0.0098},{"period":"1year","weight":-0.0105},{"period":"ytd","weight":-0.0319}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"康美药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"285909人(较上一季度减少4.79%)","perCapita":"48345股","listingDate":"2001-03-19","address":"广东省揭阳市普宁市揭神路东侧","registeredCapital":"1382889万元","survey":" 康美药业股份有限公司的主营业务是以中药饮片生产、销售为核心，实施中医药全产业链一体化运营。公司的主要产品是中药饮片、中成药、化学药、保健食品及食品。公司是国家技术创新示范企业、国家知识产权示范企业。","listedPrice":12.57},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康美药业(600518)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康美药业(600518)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康美药业,600518,康美药业股票,康美药业股票老虎,康美药业股票老虎国际,康美药业行情,康美药业股票行情,康美药业股价,康美药业股市,康美药业股票价格,康美药业股票交易,康美药业股票购买,康美药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康美药业(600518)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康美药业(600518)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}